New Analysis Shows PrimeC Significantly Improves Key miRNAs in ALS Patients
Go back to New Analysis Shows PrimeC Significantly Improves Key miRNAs in ALS Patients| (NASDAQ: NRSN) | Delayed: 0.70 -0.02 (2.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.72 | 52 Week High | $ | |||
| Open | $0.72 | 52 Week Low | $ | |||
| Day High | $0.72 | P/E | N/A | |||
| Day Low | $0.69 | EPS | $ | |||
| Volume | 70,247 | |||||

